Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Julian Harrison is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/17/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/17/2024 | RZLT | Buy Now | Rezolute | $5.00 | 160.05% | → $13 | Initiates | → Buy | Get Alert |
| 06/17/2024 | AVTE | Buy Now | Aerovate Therapeutics | $1.96 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 05/20/2024 | ABVX | Buy Now | Abivax | $13.54 | 217.58% | → $43 | Initiates | → Buy | Get Alert |
| 05/10/2024 | SYRE | Buy Now | Spyre Therapeutics | $30.89 | 29.5% | $32 → $40 | Maintains | Buy | Get Alert |
| 04/12/2024 | TBPH | Buy Now | Theravance Biopharma | $9.99 | 110.21% | → $21 | Initiates | → Buy | Get Alert |
| 03/27/2024 | OTLK | Buy Now | Outlook Therapeutics | $9.15 | 446.45% | → $50 | Upgrade | Neutral → Buy | Get Alert |
| 02/26/2024 | ANAB | Buy Now | AnaptysBio | $34.41 | 59.84% | → $55 | Initiates | → Buy | Get Alert |
| 02/13/2024 | CBAY | Buy Now | CymaBay Therapeutics | — | — | — | Downgrade | Buy → Neutral | Get Alert |
| 01/11/2024 | ACRS | Buy Now | Aclaris Therapeutics | $1.38 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 12/20/2023 | SYRE | Buy Now | Spyre Therapeutics | $30.89 | 3.6% | → $32 | Initiates | → Buy | Get Alert |
| 12/20/2023 | APGE | Buy Now | Apogee Therapeutics | $50.08 | -14.14% | → $43 | Initiates | → Buy | Get Alert |
| 11/29/2023 | AKBA | Buy Now | Akebia Therapeutics | $1.37 | 191.97% | → $4 | Assumes | → Buy | Get Alert |
| 10/11/2023 | MTNB | Buy Now | Matinas BioPharma Hldgs | $0.18 | 1540.24% | $3 → $3 | Reinstates | Buy → Buy | Get Alert |
| 09/25/2023 | MORF | Buy Now | Morphic Holding | $56.13 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 09/08/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $22 → $24 | Maintains | Buy | Get Alert |
| 08/30/2023 | OTLK | Buy Now | Outlook Therapeutics | $9.15 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 08/11/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $18 → $22 | Maintains | Buy | Get Alert |
| 07/05/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $15 → $18 | Maintains | Buy | Get Alert |
| 07/03/2023 | PTGX | Buy Now | Protagonist Therapeutics | $37.79 | 8.49% | → $41 | Reiterates | → Buy | Get Alert |
| 06/14/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.76 | 191.88% | → $46 | Initiates | → Buy | Get Alert |
| 05/15/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $15 → $15 | Maintains | Buy | Get Alert |
| 05/01/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $15 → $15 | Maintains | Buy | Get Alert |
| 03/19/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $15 → $15 | Maintains | Buy | Get Alert |
| 03/09/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | → $15 | Initiates | → Buy | Get Alert |
| 03/09/2023 | MLTX | Buy Now | MoonLake | $47.90 | -24.84% | → $36 | Initiates | → Buy | Get Alert |
| 03/07/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.38 | 2009.09% | $32 → $29 | Maintains | Buy | Get Alert |
| 12/13/2022 | KROS | Buy Now | Keros Therapeutics | $52.17 | 101.27% | $95 → $105 | Maintains | Buy | Get Alert |
| 12/08/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $74 → $181 | Maintains | Buy | Get Alert |
| 12/06/2022 | AVTE | Buy Now | Aerovate Therapeutics | $1.96 | 1277.55% | → $27 | Upgrade | Neutral → Buy | Get Alert |
| 10/31/2022 | OTLK | Buy Now | Outlook Therapeutics | $9.15 | -23.5% | → $140 | Initiates | → Buy | Get Alert |
| 10/06/2022 | ACRS | Buy Now | Aclaris Therapeutics | $1.38 | 2227.27% | → $32 | Initiates | → Buy | Get Alert |
| 10/03/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $62 → $74 | Maintains | Buy | Get Alert |
| 08/16/2022 | AVTE | Buy Now | Aerovate Therapeutics | $1.96 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 07/26/2022 | KROS | Buy Now | Keros Therapeutics | $52.17 | 53.34% | → $80 | Initiates | → Buy | Get Alert |
| 07/20/2022 | LQDA | Buy Now | Liquidia | $12.73 | 33.54% | $14 → $17 | Maintains | Buy | Get Alert |
| 05/03/2022 | PROG | Buy Now | Biora Therapeutics | — | — | → $4 | Assumes | → Buy | Get Alert |
| 02/11/2022 | AVTE | Buy Now | Aerovate Therapeutics | $1.96 | 1124.49% | → $24 | Initiates | → Buy | Get Alert |
| 02/11/2022 | UTHR | Buy Now | United Therapeutics | $336.19 | — | — | Initiates | → Neutral | Get Alert |
| 02/11/2022 | MORF | Buy Now | Morphic Holding | $56.13 | 14.03% | → $64 | Initiates | → Buy | Get Alert |
| 02/11/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | → $62 | Initiates | → Buy | Get Alert |
